Randomized control study for the effectiveness of tenofovir in nucleoside/nucleotide analogue-treated patients with chronic HBV infectio

Not Applicable

• Conditions: chronic HBV infection

• Registration Number: JPRN-UMIN000021948
• Lead Sponsor: Tohoku University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-05-01
• Study Completion: 2019-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients who is received interferon treatments (2) Patients who is taking immunosuppressive agents (3) Patients who have present or past hepatocellular carcinoma, or other malignant diseases (4) Patients who have decompensated liver cirrhosis (5) Patients who have renal dysfunction (eGFR is less than 50 ml/min/1.72m2) (6) Patients who have low serum phosphorus (less than 2.5 mg/dl) (7) Patients who are pregnant or have possibility of pregnancy (8) Breast-feeding patients (9) Patients who is infected also with HIV or HCV (10) Patients who is participating other studies (11) Patients who is considered inappropriate for this study by doctors in attendance

Study & Design

• Study Type: Interventional
• Study Design: Not specified